Skip to main content
. 2017 Jun 28;8(38):63311–63323. doi: 10.18632/oncotarget.18800

Table 1. Pharmacokinetic parameters of Bufalin and Bufalin-BSA-NP at doses of 0.15, 0.3 and 0.6 mg/kg.

Pharmacokinetic parameters 0.6 (mg/kg) 0.3 (mg/kg) 0.15 (mg/kg)
Bufalin Bufalin-BSA-NP Bufalin Bufalin-BSA-NP Bufalin Bufalin-BSA-NP
Cmax (ng/mL) 2430.5 2186.2 682.3 599.9 515.6 474.3
t1/2 (min) 43.2 127.2 39 93 34.8 75.6
MRT (min) 19.2 68.4 24.6 88.8 24 51
AUC0-8 (ng h/mL) 299.7 380.8 126.6 229.6 77.6 92.5
AUC0-∞ (ng h/mL) 302.6 389.7 128.22 233.48 78.53 94.98
Vd (L/kg) 0.64 1.76 0.95 1.90 0.76 1.34
CL (L/h kg) 2.00 1.54 2.34 1.29 1.93 1.58

Bufalin-BSA-NP: Bufalin-loaded bovine serum albumin nanoparticle; t1/2: half-life of plasma; Cmax: maximum concentration; MRT: mean residence time; AUC: area under the curve; Vd: aparent volume of distribution; CL: clearance.